Corporate Breaking News
Corporate Breaking News
Home : Nordic Nanovector: Abstracts of LYMRIT 37-01 Study With Betalutin® in NHL Patients and Other Studies Accepted for Poster Presentations at ASH
Oct 02
2018

Nordic Nanovector: Abstracts of LYMRIT 37-01 Study With Betalutin® in NHL Patients and Other Studies Accepted for Poster Presentations at ASH

OSLO, Norway, Oct. 2, 2018 /PRNewswire/ -- Nordic Nanovector ASA (OSE: NANO) announces that an abstract reporting data from the Phase 1/2a LYMRIT 37-01 study investigating Betalutin® (177Lu-lilotomab satetraxetan) in patients with relapsed/refractory indolent non-Hodgkin's lymphoma (iNHL) ...
Source:https://www.prnewswire.com:443/news-releases/nordic-nanovector-abstracts-of-lymrit-37-01-study-with-betalutin-in-nhl-patients-and-other-studies-accepted-for-poster-presentations-at-ash-300722511.html
 
Related News
» The World Gets Primed for China's National Day Holiday
» Le Centre national de recherche sur les primates de Tulane reçoit le 100e système de PET préclinique de Mediso avec l'installation du MultiScan à très grand champ de vision et extrême résolution (LFER150) pour la PET et la CT
Home
About us
Archive
Sitemap
Powered By Corporate Breaking News.com Home| About us| Archive News| Sitemap